DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Canziani LM, Trovati S, Brunetta E. et al.
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe
acute respiratory distress syndrome: A retrospective case-control survival
analysis of 128 patients.
J Autoimmun 2020;
114: 102511
DOI: 10.1016/j.jaut.2020.102511.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.